View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AP24 | Publication ID: Fall 2008 |
Title: Medicare Program; Revisions to the Medicare Advantage and Prescription Drug Benefit Programs (CMS-4131-Q) | |
Abstract: This rule codifies guidance and makes changes related to the Medicare Advantage and Prescription Drug Benefit Programs. The rule codifies guidance for special needs plans and medical savings accounts (MA program), clarifies the prescription drug bidding and novation processes, and clarifies the enrollment, appeals, and marketing processes for both programs. | |
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Long-Term Actions |
Major: No | Unfunded Mandates: State, local, or tribal governments; Private Sector |
CFR Citation: 42 CFR 422 and 423 | |
Legal Authority: MMA (PL 108-173) |
Legal Deadline:
None |
|||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: Federal |
Federalism: Yes | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Chris McClintick Health Insurance Specialist Department of Health and Human Services Centers for Medicare & Medicaid Services Centers for Drug Health Plan Choices, Mail Stop C4-22-04, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-4682 Email: chris.mcclintick@cms.hhs.gov |